To develop, through analytical, preclinical and clinical research, innovative products for the comprehensive care of diseases.
Silanes is aware that innovation and research are a major challenge in the pharmaceutical industry.
The Mexican population is exposed to diseases such as hypertension, obesity, diabetes and dyslipidemia, which is why Silanes acts in across different flanks in order to capture information, analyze and produce better products which result in health and wellbeing.
We have a collaboration agreement with the Mexican Foundation for Health (FUNSALUD) creating the ‘ANTONIO LÓPEZ DE SILANES SENIOR’ award which is given to the best project made by young researchers in the field of diabetes.
With the School of Internal Medicine of Mexico, the award is given to the university residence. This includes an internship at the Cleveland Clinic.
We have invested in analytical technology that has become more sophisticated, sensitive, precise and automated when it comes to measuring instruments. This allows for the improvement of qualitative and quantitative analysis methods, resulting in products that meet high-quality standards.